Outcomes of statin myopathy after statin withdrawal

Journal of Clinical Neuromuscular Disease

Volumn 14, Issue 3, 2013, Pages 103-109

  Armour, Ryan ^a   Zhou, Lan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CK; clinical features; EMG; outcome; statin myopathy

Indexed keywords

ATORVASTATIN; CREATINE KINASE; FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; CREATINE KINASE BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUSCLE BIOPSY; MYOPATHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; DYSLIPIDEMIAS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES;

EID: 84875411108     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e3182852558     Document Type: Article

References (12)

1. Fernandez G, Spatz ES, Jablecki C, et al. Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med. 2011;78:393-403.
2. Christopher-Stine L, Casciola-Rosen LA, Hong G, et al. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010; 62:2757-2766.
3. Grable-Esposito P, Katzberg HD, Greenberg SA, et al. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve. 2010;41:185-190.
4. Mammen AL, Chung T, Christopher-Stine L, et al. Autoantibodies against 3-hydroxy-3-methylglutarylcoenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011; 63:713-721.
5. Needham M, Fabian V, Knezevic W, et al. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord. 2007;17:194-200.
6. Hansen KE, Hildebrand JP, Ferguson EE, et al. Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med. 2005;165:2671-2676.
7. Echaniz-Laguna A, Mohr M, Tranchant C. Neuromuscular symptoms and elevated creatine kinase after statin withdrawal. N Engl J Med. 2010;362:564-565.
8. Phillips PS, Haas RH, Bannykh S, et al. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002;137:581-585.
9. Mammen AL, Amato AA. Statin myopathy: a review of recent progress. Curr Opin Rheumatol. 2010;22: 644-650.
10. McKelvie PA, Dennett X. Myopathy associated with HMG-CoA reductase inhibitors (Statins): a series of 10 patients and review of the literature. J Clin Neuromuscul Dis. 2002;3:143-148.
11. Folkers K, Langsjoen P, Willis R, et al. Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci U S A. 1990;87:8931-8934.
12. Willis RA, Folkers K, Tucker JL, et al. Lovastatin decreases coenzyme Q levels in rats. Proc Natl Acad Sci U S A. 1990;87:8928-8930.